» Articles » PMID: 24526126

Skp2: a Dream Target in the Coming Age of Cancer Therapy

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2014 Feb 15
PMID 24526126
Citations 26
Authors
Affiliations
Soon will be listed here.
Citing Articles

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.

Prabhu K, Ahmad F, Kuttikrishnan S, Leo R, Ali T, Izadi M Cell Death Discov. 2024; 10(1):225.

PMID: 38724504 PMC: 11082213. DOI: 10.1038/s41420-024-01992-7.


Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1.

Hu K, Li X, Asmamaw M, Shi X, Liu H Sci Rep. 2021; 11(1):21105.

PMID: 34702937 PMC: 8548536. DOI: 10.1038/s41598-021-00646-3.


Emerging Roles of SKP2 in Cancer Drug Resistance.

Wu T, Gu X, Cui H Cells. 2021; 10(5).

PMID: 34068643 PMC: 8150781. DOI: 10.3390/cells10051147.


Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcoma.

Wang J, Sato K, ODonnell E, Singla A, Yaguare S, Aldahamsheh O Transl Oncol. 2020; 13(10):100809.

PMID: 32623326 PMC: 7334610. DOI: 10.1016/j.tranon.2020.100809.


Paeoniflorin inhibits cell viability and invasion of liver cancer cells via inhibition of Skp2.

Liu H, Zang L, Zhao J, Wang Z, Li L Oncol Lett. 2020; 19(4):3165-3172.

PMID: 32256812 PMC: 7074174. DOI: 10.3892/ol.2020.11424.


References
1.
Chen Q, Xie W, Kuhn D, Voorhees P, Lopez-Girona A, Mendy D . Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy. Blood. 2008; 111(9):4690-9. PMC: 2343599. DOI: 10.1182/blood-2007-09-112904. View

2.
Wu L, Grigoryan A, Li Y, Hao B, Pagano M, Cardozo T . Specific small molecule inhibitors of Skp2-mediated p27 degradation. Chem Biol. 2012; 19(12):1515-24. PMC: 3530153. DOI: 10.1016/j.chembiol.2012.09.015. View

3.
Hershko D . Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer. 2008; 112(7):1415-24. DOI: 10.1002/cncr.23317. View

4.
Sakai T, Sakaue H, Nakamura T, Okada M, Matsuki Y, Watanabe E . Skp2 controls adipocyte proliferation during the development of obesity. J Biol Chem. 2006; 282(3):2038-46. DOI: 10.1074/jbc.M608144200. View

5.
Chan C, Morrow J, Li C, Gao Y, Jin G, Moten A . Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013; 154(3):556-68. PMC: 3845452. DOI: 10.1016/j.cell.2013.06.048. View